top of page

​製薬マネー論文

The Trend in Industry Payments During the COVID-19 Pandemic Among Gastroenterologists and Hepatologists in the United States

No.

Date:

Title:

55

Authors:

Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Cureus Journal of Medical Science

URL:

Trends in Industry Payments to Diabetologists and Endocrinologists in the United States During the COVID-19 Pandemic

No.

Date:

Title:

54

Authors:

Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Cureus Journal of Medical Science

URL:

Evaluation of Financial Conflicts of Interest and Quality of Evidence in Japanese Gastroenterology Clinical Practice Guidelines

No.

Date:

Title:

53

Authors:

Murayama A, Kamamoto S, Murata N, Yamasaki R, Yamada K, Yamashita E, Saito H, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

J Gastroenterol Hepatol

URL:

Financial Relationships Between Pharmaceutical Companies and Rheumatologists in Japan Between 2016 and 2019

No.

Date:

Title:

52

Authors:

Murayama A, Mamada H, Shigeta H, Yoshinaga T, Saito H, Yamashita E, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Journal of Clinical Rheumatology

URL:

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019

No.

Date:

Title:

51

Authors:

Murayama A, Hoshi M, Saito H, Kamamoto S, Tanaka M, Kawashima M, Mamada H, Kusumi E, Sapkota B, Shrestha S, Shrestha R, Bhandari D, Sawano T, Yamashita E, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Respiration

URL:

Evaluation of Financial and Non-financial Conflicts of Interest and Quality of Evidence underlying Psoriatic Arthritis Clinical Practice Guidelines–Analysis of Personal Payments from Pharmaceutical Companies and Authors’ Self-citation Rate in Japan and the United States

No.

Date:

Title:

50

Authors:

Mamada H, Murayama A, Kamamoto S, Kaneda Y, Yoshida M, Sugiura S, Yamashita E, Kusumi E, Saito H, Sawano T, Tanimoto T, Vassar M, Ozieranski P, Ozaki A

First Author:

Mamada H

Journal/Book:

Arthritis Care Res (Hoboken)

URL:

Trend in industry payments to rheumatologists in the United States during the COVID-19 pandemic between 2013 and 2021

No.

Date:

Title:

49

Authors:

Murayama A, Kamamoto S, Higuchi K, Shigeta H, Ozaki A

First Author:

Murayama A

Journal/Book:

J Rheumatol

URL:

Undisclosed financial conflicts of interest with pharmaceutical companies among the authors of the Esophageal Cancer Practice Guidelines 2017 by the Japan Esophageal Society

No.

Date:

Title:

48

Authors:

Murayama A, Kamamoto S, Shigeta H, Saito H, Yamashita E, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Dis Esophagus

URL:

Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic

No.

Date:

Title:

47

Authors:

Murayama A, Kamamoto S, Saito H, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Ann Allergy Asthma Immunol

URL:

Evaluation of financial relationships between Japanese certified pediatric hematologist/oncologists and pharmaceutical companies: a cross-sectional analysis of personal payments from pharmaceutical companies between 2016 and 2019

No.

Date:

Title:

46

Authors:

Kamamoto S, Murayama A, Kusumi E, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A

First Author:

Kamamoto S

Journal/Book:

Pediatr Blood Cancer

URL:

Trend in industry payments to infectious disease physicians in the United States: a seven-year analysis of non-research payments from Open Payments Database between 2014 and 2020

No.

Date:

Title:

45

Authors:

Murayama A, Nakano K, Kamamoto S, Sato M, Saito H, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Clin Microbiol Infect

URL:

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019

No.

Date:

Title:

44

Authors:

Murayama A, Kamamoto S, Saito H, Yamada K, Bhandari D, Shoji I, Mamada H, Kawashima M, Yamashita E, Kusumi E, Sawano T, Sapkota B, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Int J Environ Res Public Health

URL:

Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region

No.

Date:

Title:

43

Authors:

Sapkota B, Palaian S, Shrestha S, Ozaki A, Izham MIM Ibrahim, Jakovljevic M

First Author:

Sapkota B

Journal/Book:

Expert Rev Pharmacoecon Outcomes Res

URL:

Evaluation of Conflicts of Interest among Participants of the Japanese Nephrology Clinical Practice Guideline

No.

Date:

Title:

42

Authors:

Murayama A, Yamada K, Yoshida M, Kaneda Y, Saito H, Sawano T, Shrestha S, Shrestha R, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Clin J Am Soc Nephrol

URL:

A collaboration between physicians and journalists to create unbiased health information

No.

Date:

Title:

41

Authors:

Senoo Y, Ozaki A, Watanabe M, Tanimoto T

First Author:

Senoo Y

Journal/Book:

BMJ

URL:

Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019

No.

Date:

Title:

40

Authors:

Kusumi E, Murayama A, Kamamoto S, Kawashima M, Yoshida M, Saito H, Sawano T, Yamashita E, Tanimoto T, Ozaki A

First Author:

Kusumi E

Journal/Book:

Blood Cancer J

URL:

An Assessment of adherence to the WHO-delineated Good Manufacturing Practice by the pharmaceutical companies in Kabul, Afghanistan

No.

Date:

Title:

39

Authors:

Roien R, Shrestha R, Yadav K, Ozaki A, Ahmadi MB, kaneda Y, Kotera Y, Sapkota B, Shrestha S

First Author:

Roien R

Journal/Book:

Cost Effectiveness and Resource Allocation

URL:

The Diovan scandal in Japan; don’t let bygones be bygones

No.

Date:

Title:

38

Authors:

Murata N, Ozaki A, Murayama A, Sawano T, Tanimoto T

First Author:

Murata N

Journal/Book:

J Hum Hypertens

URL:

Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians

No.

Date:

Title:

37

Authors:

Murayama A, Senoo Y, Harada K, Kotera Y, Saito H, Sawano T, Suzuki Y, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

IJERPH

URL:

Generic Medicine and Generic Prescribing in Nepal: An implication for policymakers

No.

Date:

Title:

36

Authors:

Shrestha R, Shrestha S, Sapkota B, Thapa S, Ansari M, Khatiwada AP, Roien R, Ozaki A

First Author:

Shrestha R

Journal/Book:

Journal of Multidisciplinary Healthcare

URL:

How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Clinical Anesthesiology, Mie University, and Ono Pharmaceutical in Japan

No.

Date:

Title:

35

Authors:

Ozaki A, Murayama A, Harada K, Saito H, Sawano T, Tanimoto T, Ozieranski P

First Author:

Ozaki A

Journal/Book:

Frontiers in Public Health

URL:

Are Clinical Practice Guideline for Hepatitis C by the American Association for the Study of Liver Disease and Infectious Diseases Society of America Evidence-based? Financial Conflicts of Interest and Assessment of Quality of Evidence and Strength of Recommendations

No.

Date:

Title:

34

Authors:

Murayama A, Ozaki A, Saito H, Sawano T, Tanimoto T

First Author:

Murayama A

Journal/Book:

HEPATOLOGY

URL:

Evaluation of Financial Conflicts of Interest and Drug Statements in the Coronavirus Disease 2019 Clinical Practice Guideline in Japan

No.

Date:

Title:

33

Authors:

Hashimoto T, Murayama A, Mamada H, Saito H, Tanimoto T, Ozaki A

First Author:

Hashimoto T

Journal/Book:

Clin Microbiol Infect

URL:

Financial and Intellectual Conflicts of Interest Among Japanese Clinical Practice Guidelines Authors for Allergic Rhinitis

No.

Date:

Title:

31

Authors:

Murayama A, Kida F, Ozaki A, Saito H, Sawano T, Tanimoto T

First Author:

Murayama A

Journal/Book:

Otolaryngol Head Neck Surg

URL:

Japan’s conditional early approval program for innovative cancer drugs: Comparison of the regulatory processes with the US FDA and the EMA

No.

Date:

Title:

30

Authors:

Murayama A, Ueda M, Shrestha S, Tanimoto T, Ozaki A

First Author:

Murayama A

Journal/Book:

Cancer Cell

URL:

The Coverage in England of US-Approved Cancer Drugs

No.

Date:

Title:

29

Authors:

Hashimoto T, Ozaki A, Tanimoto T

First Author:

Hashimoto T

Journal/Book:

JAMA Internal Medicine

URL:

A critical appraisal of Japan's new drug approval process: a case study of FLT3-ITD inhibitor quizartinib

No.

Date:

Title:

32

Authors:

Kidoguch K, Shibusawa M, Tanimoto T

First Author:

Kidoguch K

Journal/Book:

Invest New Drugs

URL:

Industry Payments to Medical Oncologists

No.

Date:

Title:

28

Authors:

Hashimoto T, Ozaki A, Tanimoto T

First Author:

Hashimoto T

Journal/Book:

JAMA Oncology

URL:

Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir

No.

Date:

Title:

27

Authors:

Ueda M, Tanimoto T, Murayama A, Ozaki A, Kami M

First Author:

Ueda M

Journal/Book:

Clin Pharmacol Ther

URL:

Opioids: A ‘crisis’ of too much or not enough – or simply how rich you are and where you live?

No.

Date:

Title:

26

Authors:

Miyachi T, Ozaki A, Saito H, Sawano T, Tanimoto T, Crump A

First Author:

Miyachi T

Journal/Book:

Eur J Pain

URL:

Whistleblowing and Misconduct at Large Pharmaceutical Firms

No.

Date:

Title:

25

Authors:

Hashimoto T, Ozaki A, Tanimoto T

First Author:

Hashimoto T

Journal/Book:

The Journal of the American Medical Association

URL:

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension

No.

Date:

Title:

24

Authors:

Senoo Y, Hiroaki S, Ozaki A, Sawano T, Shimada Y, Yamamoto K, Suzuki Y, Tanimoto T

First Author:

Senoo Y

Journal/Book:

Medicine

URL:

Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017

No.

Date:

Title:

23

Authors:

Harada K, Ozaki A, Saito H, Sawano T, Yamamoto K, Murayama A, Senoo Y, Tanimoto T

First Author:

Harada K

Journal/Book:

Health Policy

URL:

Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017

No.

Date:

Title:

22

Authors:

Kayo Harada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Kana Yamamoto, Anju Murayama, Yuki Senoo, Tetsuya Tanimoto

First Author:

Kayo Harada

Journal/Book:

Health Policy

URL:

Covid-19 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies.

No.

Date:

Title:

20

Authors:

Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Ranjit Sah, Tetsuya Tanimoto

First Author:

Anju Murayama

Journal/Book:

Clinical Microbiology and Infection

URL:

Pharmaceutical company payments to authors of the Japanese Clinical Practice Guidelines for Hepatitis C treatment

No.

Date:

Title:

21

Authors:

Kida Futa, Anju Murayama, Hiroaki Saito, Akihiko Ozaki, Yuki Shimada, Tetsuya Tanimoto

First Author:

Kida Futa

Journal/Book:

Liver International

URL:

Pharmaceutical good manufacturing practice: Leuplin® production in Japan identifies major international shortcomings

No.

Date:

Title:

23

Authors:

Masahiro Wada, Akihiko Ozaki, Takashi Miyachi, Tetsuya Tanimoto, Andy Crump

First Author:

Masahiro Wada

Journal/Book:

Investigational New Drugs

URL:

Transparency is not enough: how can we improve the management of financial conflicts of interest between Pharma and healthcare domains?

No.

Date:

Title:

19

Authors:

Akihiko Ozaki, Anju Murayama, Hiroaki Saito, Toyoaki Sawano, Kayo Harada, Yuki Senoo, Kana Yamamoto, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Clinical Pharmacology & Therapeutics

URL:

Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan

No.

Date:

Title:

17

Authors:

Kana Yamamoto, Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Kana Yamamoto

Journal/Book:

International Urogynecology Journal

URL:

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan

No.

Date:

Title:

16

Authors:

Anju Murayama, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Anju Murayama

Journal/Book:

PLOS ONE

URL:

Accuracy of post-publication Financial Conflict of Interest corrections in medical research: a secondary analysis of pharmaceutical company payments to the authors of the CREATE-X trial report in the New England Journal of Medicine

No.

Date:

Title:

18

Authors:

Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Bioethics

URL:

Response to "Strictness and Transparency in Approval Process of Medical Products: Japanese Situation"

No.

Date:

Title:

15

Authors:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

First Author:

Toyoaki Sawano

Journal/Book:

Clinical Pharmacology & Therapeutics

URL:

Overview and Transparency of Non-research Payments to Healthcare Organizations and Healthcare Professionals from Pharmaceutical Companies in Japan: Analysis of Payment Data in 2016

No.

Date:

Title:

14

Authors:

Akihiko Ozaki, Hiroaki Saito, Yuki Senoo, Toyoaki Sawano, Yuki Shimada, Yurie Kobashi, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Health Policy

URL:

Pharmaceutical company payments to Japanese government drug regulation committee members

No.

Date:

Title:

13

Authors:

Sawano T, Ozaki A, Saito H, Shimada Y, Tanimoto T

First Author:

Toyoaki Sawano

Journal/Book:

Clinical Pharmacology & Therapeutics

URL:

Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan

No.

Date:

Title:

12

Authors:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Yosuke Suzuki, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

Journal of Bone and Joint Surgery

URL:

Japan's drug regulation framework: aiming for better health or bigger profits

No.

Date:

Title:

11

Authors:

Akihiko Ozaki, Yuki Senoo, Hiroaki Saito, Andy Crump, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

International Journal of Health Policy and Management

URL:

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

No.

Date:

Title:

10

Authors:

Yurie Kobashi, Makoto Watanabe, Hideaki Kimura, Asaka Higuchi, Akihiko Ozaki

First Author:

Yurie Kobashi

Journal/Book:

International Journal of Health Policy and Management

URL:

Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis

No.

Date:

Title:

9

Authors:

Akihiko Ozaki, Hiroaki Saito, Yosuke Onoue, Toyoaki Sawano, Yuki Shimada, Yurie Somekawa, Aritsune Tsuji, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

BMJ Open

URL:

Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

No.

Date:

Title:

8

Authors:

Hiroaki Saito, Yuta Tani, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Kana Yamamoto, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

Clinical Microbiology and Infection

URL:

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan

No.

Date:

Title:

7

Authors:

Toyoaki Sawano, Akihiko Ozaki, Hiroaki Saito, Yuki Shimada, Tetsuya Tanimoto

First Author:

Toyoaki Sawano

Journal/Book:

JAMA Network Open

URL:

Transparency of clinical evidence for medical devices in Europe

No.

Date:

Title:

6

Authors:

Tetsuya Tanimoto, Hiroaki Saito, Toyoaki Sawano, Yuki Shimada, Akihiko Ozaki

First Author:

Tetsuya Tanimoto

Journal/Book:

Lancet

URL:

Evaluation of pharmaceutical company payments and conflict of interest disclosures among oncology clinical practice guideline authors in Japan

No.

Date:

Title:

5

Authors:

Hiroaki Saito, Akihiko Ozaki, Toyoaki Sawano, Yuki Shimada, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

JAMA Network Open

URL:

Pharmaceutical company payments to executive board members of professional medical associations in Japan

No.

Date:

Title:

4

Authors:

Hiroaki Saito, Akihiko Ozaki, Yasuma Kobayashi, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Hiroaki Saito

Journal/Book:

JAMA Internal Medicine

URL:

Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016

No.

Date:

Title:

3

Authors:

Yuki Shimada, Akihiko Ozaki, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto

First Author:

Yuki Shimada

Journal/Book:

Alzheimer's & Dementia: Translational Research & Clinical Interventions

URL:

A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of medicine

No.

Date:

Title:

2

Authors:

Akihiko Ozaki, Morihito Takita, Tetsuya Tanimoto

First Author:

Akihiko Ozaki

Journal/Book:

Investigational New Drugs

URL:

Conflict of interest and the CREATE-X trial in the New England Journal of medicine

No.

Date:

Title:

1

Authors:

Akihiko Ozaki

First Author:

Akihiko Ozaki

Journal/Book:

Science and Engineering Ethics

URL:

bottom of page